Pot names love to run into the near year and ACB never ran this year like its other peers CRON, TLRY, CGC and has higher sales than all three. The only thing the company lacks is a beverage deal which will most likely attain in the future. All imo.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
